100% agree with you. I just don't see the "wins" yet unless
100% agree with you. I just don't see the "wins" yet unless you count losing by 6 instead of by 9 a "win." LOL
We're not at the bottom of our division, I am just not sure where we are as mgmt keeps us in the dark and makes hazy statements if they do speak.
Obviously I am making a bit of a joke, but you get my point. A win is a win, just like you cannot fake running a marathon because we all know what 1 mile is and what 26.2 miles is.
I'm ready for us all to start winning!
3
6
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Angel Oak Mortgage Trust 2025-1 Ratings Overview KBRA has recently assigned preliminary ratings to various classes of mortgage-backed certificates associated with Angel Oak Mortgage Trust 2025-1 (AOMT 2025-1). This substantial transaction amounts to $342.0 million and comprises non-prime residential mortgage-backed securities (RMBS). It encompasses a pool of 631...
Continue Reading
Eagle Bancorp Montana's Strong Q3 Earnings Report Eagle Bancorp Montana, Inc. (NASDAQ: EBMT), the parent entity of Opportunity Bank of Montana, recently shared its financial results for the latest quarter. With net income reaching $2.7 million, or $0.34 per diluted share, this marks an upward trend from the previous quarter’s income of $1.7 million, equivalent to $0.22...
Continue Reading
Bank of America's Performance Overview Bank of America (NYSE: BAC) has reported a mixed performance in recent times, showing resilience in its earnings even as some sectors experience challenges. The bank's stock opened slightly higher, reflecting a cautious optimism in the market with shares trading around $46.50. For the quarter, Bank of America generated $26.6 billion...
Continue Reading
The Setai St. Maarten: A Feast for the Senses In a stunning location along the coast, The Setai St. Maarten emerges as a jewel of luxury, introducing a captivating blend of elegance and tranquility to the Caribbean. This exciting new resort is poised to redefine the standards of Caribbean hospitality, creating unforgettable experiences for guests in a picturesque coastal...
Continue Reading
Cullinan Therapeutics Hosts Exciting Events at Major Conferences CAMBRIDGE, Mass. — Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a prominent biopharmaceutical firm, is set to engage the investment community with notable events at the upcoming American Society of Clinical Oncology (ASCO) Annual Meeting and the Jefferies 2025 Global Healthcare Conference. These gatherings...
Continue Reading